A startup has developed an artificial intelligence algorithm that it says can analyze results from an eye scanner and detect signs of Alzheimer’s 20 years before symptoms develop. The tool is part of broader work by startups and researchers to harness AI to unlock the mysteries of the disease.

The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule III drug, a move that would be a boon to research and patient care.

On Oct. 24, legislators, health law experts and others will dicsuss the current state of telehealth policy at the Arizona Telemedicine Program’s annual summit.

Problems with edible cannabis products in Arizona spiked in 2020 during the pandemic and have stayed at a heightened number since voters legalized recreational marijuana that year.

A new study found that reactions such as chills, fatigue, headache and malaise that can follow vaccination may be signs of a vigorous immune response.

Arizona health officials this week scaled back the state's COVID-19 dashboard and declared the disease "a common respiratory illness."

Presenting at the Alzheimer’s Research and Prevention Foundation’s annual conference in Phoenix, Roberta Diaz Brinton, PhD, director of the UArizona Center for Innovation in Brain Science, cited chronic conditions that could lead to Alzheimer's disease.

In an effort to meet the growing need for primary care physicians in Arizona, UArizona Health Sciences is working to develop a new generation of primary care physicians through the Primary Care Physician Scholarship Program, which awarded scholarships to 25 medical students this year.

A new study led by researchers in the Mel and Enid Zuckerman College of Public Health, published in the journal Vaccine, identified why less than 20% of the eligible population received COVID-19 boosters in 2022.